Delivery Order SPE2DB24D2205-SPE2DB25FDTZY

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,646.46 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,460.32 firm fixed-price delivery order is for FLAREX 0.1% eye drops, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order for $10,832.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide FLAREX 0.1% eye drops. The contract has a firm fixed price and a completion date of September 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,356.51 firm fixed price delivery order is for the supply of FLAREX 0.1% eye drops, a specialty ophthalmic medication. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this order as well as other indefinite delivery contracts (IDCs) by the DLA and Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of FLAREX 0.1% eye drops. The $24,958.18 firm fixed-price delivery order contract has a completion date of November 22, 2024 and was awarded on November 21, 2024. It is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,377.76 firm-fixed-price contract is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product, to support military treatment facilities and healthcare programs. The contract has a period of performance through July 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, holding...
This federal contract award is for the supply of FLAREX 0.1% eye drops, 5 mL, to the Defense Logistics Agency (DLA). The $8,371.50 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 2025 for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FLAREX 0.1% eye drops. The award has a ceiling value of $7,019.88 and is a firm fixed-price contract with an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this critical medical product to support the healthcare needs of military treatment facilities and other federal healthcare providers. This...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563458773 - FLAREX 0.1% EYE DROPS 5ML. The $14,382.88 order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025 to deliver a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTZY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,170.83 firm fixed-price delivery order is for the supply of 4566416958 FLAREX 0.1% eye drops, 5 ML. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. The DLA is the primary contracting agency, which is responsible for providing medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/12/25, 9:26 AM